Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ines Dufait"'
Autor:
Mariam Hebishy, Cabirou Mounchili Shintouo, Ines Dufait, Florence Debacq-Chainiaux, Ivan Bautmans, Rose Njemini
Publikováno v:
Archives of Gerontology and Geriatrics. 113:105057
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::945da80738caecfa37976f25a0cd0348
https://doi.org/10.1016/j.archger.2023.105057
https://doi.org/10.1016/j.archger.2023.105057
Radiomics has the potential of characterizing the tumor phenotype hidden in medical images, allowing us to get more out of medical images than the eyes can see and liberating us from only using lesion size as a tumor response criterion. The extracted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d89d62b91c14a2ad49caa4d03763a37
https://biblio.vub.ac.be/vubir/unraveling-the-biological-meaning-of-radiomic-features(32637e89-caff-425e-991a-a60e30d2b050).html
https://biblio.vub.ac.be/vubir/unraveling-the-biological-meaning-of-radiomic-features(32637e89-caff-425e-991a-a60e30d2b050).html
Autor:
Johnny Duerinck, Gil Awada, Julia Katharina Schwarze, Ines Dufait, Stephanie Peeters, Laura Seynave, Anne-marie Van Binst, Hendrik Everaert, Alex Michotte, Anne Rogiers, Vera Van Velthoven, Bart Neyns
Publikováno v:
Neuro Oncol
INTRODUCTION Intravenous (iv) administration of PD-1 blocking mAb is largely ineffective for the treatment of recurrent glioblastoma (rGB). Combination of iv-ipilimumab (IPI) plus nivolumab (NIVO) is associated with a high incidence of irAE. Intracer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50952fea1738c1a1fab84ad9228fd096
https://europepmc.org/articles/PMC6847104/
https://europepmc.org/articles/PMC6847104/
Autor:
Bart Neyns, Bart Ilsen, Jens Tijtgat, Frederik Vandenbroucke, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Steven Raemaeckers, Selma Ben Mustapha, Jens Van Loon, Lore Decoster, Mark De Ridder
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0f9eaaab49f04c17bf3c5ca729d63bdc
Autor:
Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, Hajar Hazime, Inès Dufait, Jashodeep Datta, Saratchandra Singh Khumukcham, Mark De Ridder, Jatin Roper, Maria T. Abreu, Karine Breckpot, Kevin Van der Jeught
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 8, Pp 1103-1119 (2023)
Cancer immunotherapy has become an indispensable mode of treatment for a multitude of solid tumor cancers. Colorectal cancer (CRC) has been one of the many cancer types to benefit from immunotherapy, especially in advanced disease where standard trea
Externí odkaz:
https://doaj.org/article/7a853b37793742bdb339c632a4618df9
Autor:
Therese, Liechtenstein, Noemi, Perez-Janices, Idoia, Blanco-Luquin, Cleo, Goyvaerts, Julia, Schwarze, Ines, Dufait, Alessio, Lanna, Mark De, Ridder, David, Guerrero-Setas, Karine, Breckpot, David, Escors
Publikováno v:
Oncoimmunology. 3(7)
Efficacious antitumor vaccines strongly stimulate cancer-specific effector T cells and counteract the activity of tumor-infiltrating immunosuppressive cells. We hypothesised that combining cytokine expression with silencing programmed cell death liga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5512fab060e521742e006af27ba37f90
https://pubmed.ncbi.nlm.nih.gov/25954597
https://pubmed.ncbi.nlm.nih.gov/25954597
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bart Neyns, Angela Vasaturo, Julia Katharina Schwarze, Gil Awada, Ramses Forsyth, Jens Tijtgat, Louise Cras, Christopher Bagnall, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Intratumoral (IT) myeloid dendritic cells (myDCs) play a pivotal role in initiating antitumor immune responses and relicensing of anti-tumor cytotoxic T lymphocytes within the tumor microenvironment. Talimogene laherparepvec (T-VEC) induce
Externí odkaz:
https://doaj.org/article/dd95b87c21364e25bbd675961d316525
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Although radiotherapy is given to more than 50% of cancer patients, little progress has been made in identifying optimal radiotherapy - drug combinations to improve treatment efficacy. Using molecular data from The Cancer Genome Atlas (TCGA), we extr
Externí odkaz:
https://doaj.org/article/e50ab6e94c7f4f74ba85ba2a44e48975
Autor:
Jens Tijtgat, Jolien De Munck, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Lorenzo Franceschini, Karine Breckpot, Joeri L. Aerts, Bart Neyns, Sandra Tuyaerts
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediat
Externí odkaz:
https://doaj.org/article/15bec737d36f4fb1acbc36e0fe41b1da